Cargando…
In-Depth Analysis of the Impact of Different Serum-Free Media on the Production of Clinical Grade Dendritic Cells for Cancer Immunotherapy
Dendritic cell (DC)-based antitumor vaccines have proven to be a safe approach, but often fail to generate robust results between trials. Translation to the clinic has been hindered in part by the lack of standard operation procedures for vaccines production, namely the definition of optimal culture...
Autores principales: | Calmeiro, João, Mendes, Luís, Duarte, Iola F., Leitão, Catarina, Tavares, Adriana R., Ferreira, Daniel Alexandre, Gomes, Célia, Serra, João, Falcão, Amílcar, Cruz, Maria Teresa, Carrascal, Mylène A., Neves, Bruno Miguel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893095/ https://www.ncbi.nlm.nih.gov/pubmed/33613517 http://dx.doi.org/10.3389/fimmu.2020.593363 |
Ejemplares similares
-
Biomaterial-based platforms for in situ dendritic cell programming and their use in antitumor immunotherapy
por: Calmeiro, João, et al.
Publicado: (2019) -
Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells
por: Calmeiro, João, et al.
Publicado: (2020) -
A versatile synthesis method of dendrites-free segmented nanowires with a precise size control
por: Sousa, Célia T, et al.
Publicado: (2012) -
Targeting PCSK9: a promising adjuvant strategy in cancer immunotherapy
por: Almeida, Catarina R., et al.
Publicado: (2021) -
Flavonoid-mediated immunomodulation of human macrophages involves key metabolites and metabolic pathways
por: Mendes, Luís F., et al.
Publicado: (2019)